)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
OptimizeRx
OptimizeRx (OPRX) investor relations material
OptimizeRx Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary11 Nov, 2026
Executive summary
Q3 revenue was $21.615M, down 17% YoY, while adjusted EBITDA rose to $6.295M from $5.107M.
FY2026 revenue guidance was reduced to $87M–$93M; adjusted EBITDA guidance remained $21M–$25M.
Early 2027 contracted revenue was tracking ~20% ahead YoY during RFP season, while Q4 conversion remained uncertain.
Financial highlights
Q3 revenue was $21.615M vs. $26.067M a year earlier; 9M revenue was $61.963M vs. $77.190M.
Q3 adjusted EBITDA rose to $6.295M from $5.107M despite lower revenue.
Q3 expenses fell $5.1M YoY to $18.9M, including $0.7M of severance costs.
Q3 GAAP net income was $1.195M, or $0.06 per share; adjusted net income was $3.835M, or $0.20 per diluted share.
Q3 operating income was $2.670M vs. $2.071M a year earlier.
Outlook and guidance
FY2026 revenue guidance was lowered to $87M–$93M; adjusted EBITDA guidance was maintained at $21M–$25M.
2026 contracted revenue was ~20% below the comparable prior year; more than 90% of revenue needed for the guidance midpoint was contracted, vs. a mid-90% range in prior years.
Q4 delivery depends on timing and conversion of customer buy-ups; visibility into contracting, delivering and recognizing remaining budgets before year-end was limited.
Early 2027 contracted revenue was tracking ~20% ahead YoY during RFP season; management said it was too early to provide 2027 guidance.
Management expected FY2026 gross margin in the low-70% range and cited cost reductions as support for EBITDA guidance.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from OptimizeRx
- Omnichannel healthcare reach pairs with FY2026 revenue guidance of $95M-$100M.OPRX
Corporate presentation - Q2 revenue and EBITDA beat expectations; guidance reaffirmed amid margin gains and industry headwinds.OPRXQ2 2026
- AI-powered healthcare platform drives pharma engagement and revenue growth.OPRXCorporate presentation
- Directors elected, executive pay and equity plan increase approved, evergreen provision rejected.OPRXAGM 2026
- AI-powered point-of-care platform drives pharma ROI and growth through EHR integration and DSPs.OPRX46th Annual William Blair Growth Stock Conference
- Proposal seeks a five-year evergreen equity plan amendment with strong governance and oversight.OPRXProxy filing
- Q1 2026 revenue fell 10%, but profitability improved and guidance remains strong.OPRXQ1 2026
- Record 2025 growth, margin expansion, and $10M buyback set a strong but cautious 2026 outlook.OPRXQ4 2025
- Q2 2024 revenue up 36% to $18.8M, gross margin 62.2%, and strong DAAP momentum.OPRXQ2 2024
Next OptimizeRx earnings date
Q4 20263 Mar, 2027
OptimizeRx
Next OptimizeRx earnings date
Q4 20263 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
OptimizeRx Corporation provides software solutions that help doctors and their staff to improve communication with patients through various mobile channels. It also enables pharmacies to integrate patient support programs directly into the pharmacy workflow. In addition, the company offers electronic coupon technology, which enables pharma companies to securely and seamlessly deliver a variety of valuable offers for their products directly to prescribers within their existing workflows. The company was found in 2006 and is headquartered in Rochester, Michigan.